Li-Fang Hu Selected Research

Li-Fang Hu Research Topics

Disease

20	Parkinson Disease (Parkinson's Disease) 12/2021 - 06/2005
9	Inflammation (Inflammations) 01/2018 - 02/2007
5	Neuroinflammatory Diseases 12/2021 - 01/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 07/2011
3	Ischemia 11/2011 - 01/2008
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Olfaction Disorders (Cacosmia) 01/2019
1	Disease Progression 05/2017
1	Pain (Aches) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Hyperalgesia 01/2017
1	Thrombosis (Thrombus) 06/2016
1	Atherosclerosis 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 11/2015
1	Ureteral Obstruction 06/2014
1	Chronic Renal Insufficiency 06/2014
1	Fibrosis (Cirrhosis) 06/2014
1	Reperfusion Injury 11/2011
1	Acidosis 06/2011
1	Pheochromocytoma 06/2011
1	Osteoporosis 05/2011
1	Neuroblastoma 01/2009
1	Wounds and Injuries (Trauma) 12/2008
1	Shock 12/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2008
1	Catalepsy 06/2005

Drug/Important Bio-Agent (IBA)

15	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2021 - 02/2007
5	SynucleinsIBA 12/2021 - 06/2011
4	Neurotransmitter Agents (Neurotransmitter)IBA 11/2021 - 12/2008
4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020 - 01/2017
3	Uric Acid (Urate)IBA 11/2017 - 12/2012
3	RotenoneIBA 01/2017 - 01/2009
3	Neuroprotective AgentsIBA 11/2016 - 04/2010
3	sodium bisulfide (NaHS)IBA 06/2016 - 03/2008
3	LyasesIBA 01/2016 - 11/2013
3	CystathionineIBA 01/2016 - 11/2013
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 02/2005
2	Oxidopamine (6 Hydroxydopamine)IBA 05/2017 - 06/2005
2	Levodopa (L Dopa)FDA LinkGeneric 05/2017 - 01/2013
2	LipopolysaccharidesIBA 01/2013 - 02/2007
2	Glutamic Acid (Glutamate)FDA Link 12/2008 - 02/2005
1	Muramidase (Lysozyme)IBA 12/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Nicotine FDA Link 01/2019
1	perifosineIBA 01/2018
1	5,7-Dihydroxytryptamine (5,7 Dihydroxytryptamine)IBA 01/2017
1	Citalopram FDA LinkGeneric 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	GYY 4137IBA 01/2017
1	PesticidesIBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	peoniflorinIBA 11/2016
1	Rose BengalIBA 06/2016
1	ferric chlorideIBA 06/2016
1	LipidsIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Dopamine Agonists (Dopamine Agonist)IBA 11/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015
1	CytokinesIBA 09/2015
1	HomocysteineIBA 06/2015
1	GasotransmittersIBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2014
1	CollagenIBA 06/2014
1	SodiumIBA 06/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Dyneins (Dynein)IBA 12/2013
1	oxidized low density lipoproteinIBA 11/2013
1	ACS 84IBA 01/2013
1	Therapeutic UsesIBA 01/2013
1	Guanidine (Guanidine Nitrate)FDA Link 11/2011
1	furanIBA 11/2011
1	cariporideIBA 11/2011
1	AntioxidantsIBA 07/2011
1	Protons (Proton)IBA 06/2011
1	NeurotoxinsIBA 04/2010
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2008
1	WastewaterIBA 12/2008
1	HydrogenIBA 04/2008
1	Adrenergic Receptors (Adrenergic Receptor)IBA 04/2008
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 03/2008
1	Celecoxib (Celebrex)FDA Link 03/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2008
1	CoagulantsIBA 01/2008
1	Protein Kinase CIBA 01/2008
1	MetalsIBA 01/2008
1	IonsIBA 01/2008
1	p38 Mitogen-Activated Protein KinasesIBA 02/2007
1	Adenosine Triphosphate (ATP)IBA 09/2005
1	PotassiumIBA 09/2005
1	KATP ChannelsIBA 06/2005
1	Haloperidol (Haldol)FDA LinkGeneric 06/2005
1	metabotropic glutamate receptor 8IBA 02/2005
1	metabotropic glutamate receptor 3 (mGluR3)IBA 02/2005
1	Messenger RNA (mRNA)IBA 02/2005
1	metabotropic glutamate receptor 6IBA 02/2005

Therapy/Procedure

3	Therapeutics 05/2017 - 01/2014
2	Intraperitoneal Injections 01/2013 - 06/2005
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2016